1
|
Saw PE, Cui GH, Xu X. Nanoparticles-mediated CRISPR/Cas gene editing delivery system. ChemMedChem 2022; 17:e202100777. [PMID: 35261159 DOI: 10.1002/cmdc.202100777] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Revised: 03/06/2022] [Indexed: 11/09/2022]
Abstract
The CRISPR/Cas gene editing system utilizes CRISPR RNA to guide the endonuclease in specifically breaking target gene, and then repairs genomic DNA by the means of homology directed repair (HDR) and non-homologous end joining (NHEJ). The gene editing system can only play its role in gene editing when it enters the nucleus. This crucial step in the process of gene editing is the major hurdle to gene therapy as it is still a huge challenge to efficiently deliver the CRISPR/Cas system to target tissues and cells. The low delivery efficiency hinders the clinical transformation of this technology. At present, delivery systems mainly include physical methods, viral vectors, and non-viral vectors. Due to the advantages of nanomaterial, it is currently being used rapidly in developing non-viral delivery systems. This review focuses on the mechanism of CRISPR/Cas and the delivery of gene editing system, following the research progress of nanoparticle-mediated gene editing.
Collapse
Affiliation(s)
- Phei Er Saw
- Sun Yat-Sen Memorial Hospital, 107 West Yanjiang Road, 510000, Guangzhou, CHINA
| | - Guo-Hui Cui
- Sun Yat-sen University Zhongshan School of Medicine, Bio-safety Laboratory, CHINA
| | - Xiaoding Xu
- Sun Yat-Sen Memorial Hospital, Medical Research Center, CHINA
| |
Collapse
|
2
|
Li X, Pan Y, Chen C, Gao Y, Liu X, Yang K, Luan X, Zhou D, Zeng F, Han X, Song Y. Hypoxia‐Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild‐Photothermal Therapy. Angew Chem Int Ed Engl 2021. [DOI: 10.1002/ange.202107036] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Xueqing Li
- College of Engineering and Applied Sciences Jiangsu Key Laboratory of Artificial Functional Materials State Key Laboratory of Analytical Chemistry for Life Science Nanjing University Nanjing 210023 China
| | - Yongchun Pan
- College of Engineering and Applied Sciences Jiangsu Key Laboratory of Artificial Functional Materials State Key Laboratory of Analytical Chemistry for Life Science Nanjing University Nanjing 210023 China
| | - Chao Chen
- School of Medicine & Holistic Integrative Medicine Jiangsu Collaborative Innovation Canter of Chinese Medicinal Resources Industrialization Nanjing University of Chinese Medicine Nanjing 210023 China
| | - Yanfeng Gao
- College of Engineering and Applied Sciences Jiangsu Key Laboratory of Artificial Functional Materials State Key Laboratory of Analytical Chemistry for Life Science Nanjing University Nanjing 210023 China
| | - Xinli Liu
- College of Engineering and Applied Sciences Jiangsu Key Laboratory of Artificial Functional Materials State Key Laboratory of Analytical Chemistry for Life Science Nanjing University Nanjing 210023 China
| | - Kaiyong Yang
- School of Medicine & Holistic Integrative Medicine Jiangsu Collaborative Innovation Canter of Chinese Medicinal Resources Industrialization Nanjing University of Chinese Medicine Nanjing 210023 China
| | - Xiaowei Luan
- College of Engineering and Applied Sciences Jiangsu Key Laboratory of Artificial Functional Materials State Key Laboratory of Analytical Chemistry for Life Science Nanjing University Nanjing 210023 China
| | - Dongtao Zhou
- College of Engineering and Applied Sciences Jiangsu Key Laboratory of Artificial Functional Materials State Key Laboratory of Analytical Chemistry for Life Science Nanjing University Nanjing 210023 China
| | - Fei Zeng
- College of Engineering and Applied Sciences Jiangsu Key Laboratory of Artificial Functional Materials State Key Laboratory of Analytical Chemistry for Life Science Nanjing University Nanjing 210023 China
| | - Xin Han
- School of Medicine & Holistic Integrative Medicine Jiangsu Collaborative Innovation Canter of Chinese Medicinal Resources Industrialization Nanjing University of Chinese Medicine Nanjing 210023 China
| | - Yujun Song
- College of Engineering and Applied Sciences Jiangsu Key Laboratory of Artificial Functional Materials State Key Laboratory of Analytical Chemistry for Life Science Nanjing University Nanjing 210023 China
| |
Collapse
|
3
|
Li X, Pan Y, Chen C, Gao Y, Liu X, Yang K, Luan X, Zhou D, Zeng F, Han X, Song Y. Hypoxia-Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild-Photothermal Therapy. Angew Chem Int Ed Engl 2021; 60:21200-21204. [PMID: 34297462 DOI: 10.1002/anie.202107036] [Citation(s) in RCA: 60] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Indexed: 01/17/2023]
Abstract
Near-infrared (NIR)-light-triggered photothermal therapy (PTT) is usually associated with undesirable damage to healthy organs nearby due to the high temperatures (>50 °C) available for tumor ablation. Low-temperature PTT would therefore have tremendous value for clinical application. Here, we construct a hypoxia-responsive gold nanorods (AuNRs)-based nanocomposite of CRISPR-Cas9 for mild-photothermal therapy via tumor-targeted gene editing. AuNRs are modified with azobenzene-4,4'-dicarboxylic acid (p-AZO) to achieve on-demand release of CRISPR-Cas9 using hypoxia-responsive azo bonds. In the hypoxic tumor microenvironment, the azo groups of the hypoxia-activated CRISPR-Cas9 nanosystem based on gold nanorods (APACPs) are selectively reduced by the overexpression of reductases, leading to the release of Cas9 and subsequent gene editing. Owing to the knockout of HSP90α for reducing the thermal resistance of cancer cells, highly effective tumor ablation both in vitro and in vivo was achieved with APACPs under mild PTT.
Collapse
Affiliation(s)
- Xueqing Li
- College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China
| | - Yongchun Pan
- College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China
| | - Chao Chen
- School of Medicine & Holistic Integrative Medicine, Jiangsu Collaborative Innovation Canter of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, 210023, China
| | - Yanfeng Gao
- College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China
| | - Xinli Liu
- College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China
| | - Kaiyong Yang
- School of Medicine & Holistic Integrative Medicine, Jiangsu Collaborative Innovation Canter of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, 210023, China
| | - Xiaowei Luan
- College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China
| | - Dongtao Zhou
- College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China
| | - Fei Zeng
- College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China
| | - Xin Han
- School of Medicine & Holistic Integrative Medicine, Jiangsu Collaborative Innovation Canter of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, 210023, China
| | - Yujun Song
- College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China
| |
Collapse
|
4
|
Wu J, Peng H, Lu X, Lai M, Zhang H, Le XC. Binding-Mediated Formation of Ribonucleoprotein Corona for Efficient Delivery and Control of CRISPR/Cas9. Angew Chem Int Ed Engl 2021; 60:11104-11109. [PMID: 33354860 PMCID: PMC8252003 DOI: 10.1002/anie.202014162] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Revised: 11/27/2020] [Indexed: 01/26/2023]
Abstract
Protein coronae formed with nanoparticles confer several useful properties. However, the non-specific nature of protein corona formation makes it difficult to deliver specific proteins for therapeutic applications. Herein, we report on the construction of a new type of protein corona, termed binding-mediated protein corona. This new corona enables the efficient and controllable delivery of functional proteins, which is otherwise challenging for conventional protein coronae. We show the design and delivery of the ribonucleoprotein corona for the CRISPR/Cas9 system. Successful gene editing in human cell lines (Hela and HEK293) demonstrates the efficient delivery, high stability, low cytotoxicity, and well-controlled activity of the Cas9-guide RNA ribonucleoprotein. The binding-mediated protein corona strategy opens up new opportunities for therapeutic protein delivery.
Collapse
Affiliation(s)
- Jinjun Wu
- Division of Analytical and Environmental ToxicologyDepartment of Laboratory Medicine and PathologyFaculty of Medicine and DentistryUniversity of AlbertaEdmontonAlbertaT6G 2G3Canada
| | - Hanyong Peng
- Division of Analytical and Environmental ToxicologyDepartment of Laboratory Medicine and PathologyFaculty of Medicine and DentistryUniversity of AlbertaEdmontonAlbertaT6G 2G3Canada
| | - Xiufen Lu
- Division of Analytical and Environmental ToxicologyDepartment of Laboratory Medicine and PathologyFaculty of Medicine and DentistryUniversity of AlbertaEdmontonAlbertaT6G 2G3Canada
| | - Maode Lai
- Department of PathologyZhejiang University School of MedicineHangzhouZhejiang310058China
| | - Hongquan Zhang
- Division of Analytical and Environmental ToxicologyDepartment of Laboratory Medicine and PathologyFaculty of Medicine and DentistryUniversity of AlbertaEdmontonAlbertaT6G 2G3Canada
| | - X. Chris Le
- Division of Analytical and Environmental ToxicologyDepartment of Laboratory Medicine and PathologyFaculty of Medicine and DentistryUniversity of AlbertaEdmontonAlbertaT6G 2G3Canada
| |
Collapse
|
5
|
Wu J, Peng H, Lu X, Lai M, Zhang H, Le XC. Binding‐Mediated Formation of Ribonucleoprotein Corona for Efficient Delivery and Control of CRISPR/Cas9. Angew Chem Int Ed Engl 2021. [DOI: 10.1002/ange.202014162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Jinjun Wu
- Division of Analytical and Environmental Toxicology Department of Laboratory Medicine and Pathology Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta T6G 2G3 Canada
| | - Hanyong Peng
- Division of Analytical and Environmental Toxicology Department of Laboratory Medicine and Pathology Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta T6G 2G3 Canada
| | - Xiufen Lu
- Division of Analytical and Environmental Toxicology Department of Laboratory Medicine and Pathology Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta T6G 2G3 Canada
| | - Maode Lai
- Department of Pathology Zhejiang University School of Medicine Hangzhou Zhejiang 310058 China
| | - Hongquan Zhang
- Division of Analytical and Environmental Toxicology Department of Laboratory Medicine and Pathology Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta T6G 2G3 Canada
| | - X. Chris Le
- Division of Analytical and Environmental Toxicology Department of Laboratory Medicine and Pathology Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta T6G 2G3 Canada
| |
Collapse
|
6
|
Cai W, Luo T, Mao L, Wang M. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli‐Responsive Vehicles. Angew Chem Int Ed Engl 2021. [DOI: 10.1002/ange.202005644] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Weiqi Cai
- Beijing National Laboratory for Molecular Science CAS Key Laboratory of Analytical Chemistry for Living Biosystems Institute of Chemistry Chinese Academy of Sciences (ICCAS) No. 2, North first street Zhongguancun Beijing 100190 China
- University of Chinese Academy of Sciences No.19 (A) Yuquan Road Shijingshan District China
| | - Tianli Luo
- Beijing National Laboratory for Molecular Science CAS Key Laboratory of Analytical Chemistry for Living Biosystems Institute of Chemistry Chinese Academy of Sciences (ICCAS) No. 2, North first street Zhongguancun Beijing 100190 China
- University of Chinese Academy of Sciences No.19 (A) Yuquan Road Shijingshan District China
| | - Lanqun Mao
- Beijing National Laboratory for Molecular Science CAS Key Laboratory of Analytical Chemistry for Living Biosystems Institute of Chemistry Chinese Academy of Sciences (ICCAS) No. 2, North first street Zhongguancun Beijing 100190 China
- University of Chinese Academy of Sciences No.19 (A) Yuquan Road Shijingshan District China
| | - Ming Wang
- Beijing National Laboratory for Molecular Science CAS Key Laboratory of Analytical Chemistry for Living Biosystems Institute of Chemistry Chinese Academy of Sciences (ICCAS) No. 2, North first street Zhongguancun Beijing 100190 China
- University of Chinese Academy of Sciences No.19 (A) Yuquan Road Shijingshan District China
| |
Collapse
|
7
|
Seaberg J, Montazerian H, Hossen MN, Bhattacharya R, Khademhosseini A, Mukherjee P. Hybrid Nanosystems for Biomedical Applications. ACS NANO 2021; 15:2099-2142. [PMID: 33497197 PMCID: PMC9521743 DOI: 10.1021/acsnano.0c09382] [Citation(s) in RCA: 68] [Impact Index Per Article: 22.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
Inorganic/organic hybrid nanosystems have been increasingly developed for their versatility and efficacy at overcoming obstacles not readily surmounted by nonhybridized counterparts. Currently, hybrid nanosystems are implemented for gene therapy, drug delivery, and phototherapy in addition to tissue regeneration, vaccines, antibacterials, biomolecule detection, imaging probes, and theranostics. Though diverse, these nanosystems can be classified according to foundational inorganic/organic components, accessory moieties, and architecture of hybridization. Within this Review, we begin by providing a historical context for the development of biomedical hybrid nanosystems before describing the properties, synthesis, and characterization of their component building blocks. Afterward, we introduce the architectures of hybridization and highlight recent biomedical nanosystem developments by area of application, emphasizing hybrids of distinctive utility and innovation. Finally, we draw attention to ongoing clinical trials before recapping our discussion of hybrid nanosystems and providing a perspective on the future of the field.
Collapse
Affiliation(s)
- Joshua Seaberg
- Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73104, USA
| | - Hossein Montazerian
- Department of Bioengineering, University of California-Los Angeles, Los Angeles, CA 90095, USA
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, Los Angeles, CA 90095, USA
- Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA 90024, USA
| | - Md Nazir Hossen
- Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73104, USA
- Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
| | - Resham Bhattacharya
- Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
| | - Ali Khademhosseini
- Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA 90024, USA
| | - Priyabrata Mukherjee
- Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73104, USA
- Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
| |
Collapse
|
8
|
Cai W, Luo T, Mao L, Wang M. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles. Angew Chem Int Ed Engl 2020; 60:8596-8606. [PMID: 32385892 DOI: 10.1002/anie.202005644] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2020] [Indexed: 12/17/2022]
Abstract
Recent innovations in genome editing have enabled the precise manipulation of the genetic information of mammalians, and benefitted the development of next-generation gene therapy. Despite these advances, several barriers to the clinical translation of genome editing remain, including the intracellular delivery of genome editing machinery, and the risk of off-target editing effect. Here, we review the recent advance of spatiotemporal delivery of CRISPR/Cas9 genome editing machinery, which is composed of programmable Cas9 nuclease and a single-guide RNA (sgRNA) using stimuli-responsive nanoparticles. We discuss the specific chemistries that have been used for controlled Cas9/sgRNA delivery and intracellular release in the presence of endogenous or external signals. These methodologies can leverage biological signals found locally within disease cells, or exogenous signals administrated with spatiotemporal control, through which an improved genome editing could be achieved. We also discuss the future in exploiting these approaches for fundamental biomedical applications and therapeutic genome editing.
Collapse
Affiliation(s)
- Weiqi Cai
- Beijing National Laboratory for Molecular Science, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences (ICCAS), No. 2, North first street, Zhongguancun, Beijing, 100190, China.,University of Chinese Academy of Sciences, No.19 (A) Yuquan Road, Shijingshan District, China
| | - Tianli Luo
- Beijing National Laboratory for Molecular Science, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences (ICCAS), No. 2, North first street, Zhongguancun, Beijing, 100190, China.,University of Chinese Academy of Sciences, No.19 (A) Yuquan Road, Shijingshan District, China
| | - Lanqun Mao
- Beijing National Laboratory for Molecular Science, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences (ICCAS), No. 2, North first street, Zhongguancun, Beijing, 100190, China.,University of Chinese Academy of Sciences, No.19 (A) Yuquan Road, Shijingshan District, China
| | - Ming Wang
- Beijing National Laboratory for Molecular Science, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences (ICCAS), No. 2, North first street, Zhongguancun, Beijing, 100190, China.,University of Chinese Academy of Sciences, No.19 (A) Yuquan Road, Shijingshan District, China
| |
Collapse
|
9
|
Lyu Y, He S, Li J, Jiang Y, Sun H, Miao Y, Pu K. A Photolabile Semiconducting Polymer Nanotransducer for Near‐Infrared Regulation of CRISPR/Cas9 Gene Editing. Angew Chem Int Ed Engl 2019. [DOI: 10.1002/ange.201909264] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Yan Lyu
- School of Chemical and Biomedical EngineeringNanyang Technological University 70 Nanyang Drive Singapore 637457 Singapore
| | - Shasha He
- School of Chemical and Biomedical EngineeringNanyang Technological University 70 Nanyang Drive Singapore 637457 Singapore
| | - Jingchao Li
- School of Chemical and Biomedical EngineeringNanyang Technological University 70 Nanyang Drive Singapore 637457 Singapore
| | - Yuyan Jiang
- School of Chemical and Biomedical EngineeringNanyang Technological University 70 Nanyang Drive Singapore 637457 Singapore
| | - He Sun
- School of Biological ScienceNanyang Technological University 60 Nanyang Drive Singapore 637551 Singapore
| | - Yansong Miao
- School of Chemical and Biomedical EngineeringNanyang Technological University 70 Nanyang Drive Singapore 637457 Singapore
- School of Biological ScienceNanyang Technological University 60 Nanyang Drive Singapore 637551 Singapore
| | - Kanyi Pu
- School of Chemical and Biomedical EngineeringNanyang Technological University 70 Nanyang Drive Singapore 637457 Singapore
| |
Collapse
|
10
|
Lyu Y, He S, Li J, Jiang Y, Sun H, Miao Y, Pu K. A Photolabile Semiconducting Polymer Nanotransducer for Near-Infrared Regulation of CRISPR/Cas9 Gene Editing. Angew Chem Int Ed Engl 2019; 58:18197-18201. [PMID: 31566854 DOI: 10.1002/anie.201909264] [Citation(s) in RCA: 86] [Impact Index Per Article: 17.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2019] [Revised: 09/27/2019] [Indexed: 12/12/2022]
Abstract
Noninvasive regulation of CRISPR/Cas9 gene editing is conducive to understanding of gene function and development of gene therapy; however, it remains challenging. Herein, a photolabile semiconducting polymer nanotransducer (pSPN) is synthesized to act as the gene vector to deliver CRISPR/Cas9 plasmids into cells and also as the photoregulator to remotely activate gene editing. pSPN comprises a 1 O2 -generating backbone grafted with polyethylenimine brushes through 1 O2 -cleavable linkers. NIR photoirradiation spontaneously triggers the cleavage of gene vectors from pSPN, resulting in the release of CRISPR/Cas9 plasmids and subsequently initiating gene editing. This system affords 15- and 1.8-fold enhancement in repaired gene expression relative to the nonirradiated controls in living cells and mice, respectively. As this approach does not require any specific modifications on biomolecular components, pSPN represents the first generic nanotransducer for in vivo regulation of CRISPR/Cas9 gene editing.
Collapse
Affiliation(s)
- Yan Lyu
- School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore
| | - Shasha He
- School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore
| | - Jingchao Li
- School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore
| | - Yuyan Jiang
- School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore
| | - He Sun
- School of Biological Science, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore
| | - Yansong Miao
- School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore.,School of Biological Science, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore
| | - Kanyi Pu
- School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore
| |
Collapse
|
11
|
Zhang L, Wang L, Xie Y, Wang P, Deng S, Qin A, Zhang J, Yu X, Zheng W, Jiang X. Triple-Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases. Angew Chem Int Ed Engl 2019; 58:12404-12408. [PMID: 31318118 DOI: 10.1002/anie.201903618] [Citation(s) in RCA: 90] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Revised: 06/14/2019] [Indexed: 12/25/2022]
Abstract
A high level of low-density lipoprotein cholesterol (LDL-C) in the blood is a major risk factor for coronary heart disease. Herein, we present a triple-targeting strategy to generate a loss-of-function mutation in Pcsk9, which regulates plasma cholesterol levels, using a nanocarrier-delivered CRISPR/Cas9 system. Nuclear localization signal (NLS)-tagged Cas9 and Pcsk9-targeted single guide RNA (sgPcsk9) were complexed with gold nanoclusters (GNCs) modified with cationic HIV-1-transactivating transcriptor (TAT) peptide and further encapsulated in a galactose-modified lipid layer to target the nanoclusters to the liver. The resulting nanoclusters had an in vitro Pcsk9-editing efficiency of about 60 % and resulting in a decrease in plasma LDL-C in mice of approximately 30%. No off-target mutagenesis was detected in 10 sites with high similarity. This approach may have therapeutic potential for the prevention and treatment of cardiovascular disease without side effects.
Collapse
Affiliation(s)
- Lingmin Zhang
- CAS Center for Excellence in Nanoscience, Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology, No. 11, BeiYiTiao, ZhongGuanCun, Beijing, 100190, China.,Guangdong Key Laboratory of Molecular Target &, Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third & Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China
| | - Le Wang
- CAS Center for Excellence in Nanoscience, Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology, No. 11, BeiYiTiao, ZhongGuanCun, Beijing, 100190, China
| | - Yangzhouyun Xie
- CAS Center for Excellence in Nanoscience, Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology, No. 11, BeiYiTiao, ZhongGuanCun, Beijing, 100190, China
| | - Peng Wang
- CAS Center for Excellence in Nanoscience, Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology, No. 11, BeiYiTiao, ZhongGuanCun, Beijing, 100190, China
| | - Sai Deng
- Guangdong Key Laboratory of Molecular Target &, Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third & Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China
| | - Aiping Qin
- Guangdong Key Laboratory of Molecular Target &, Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third & Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China
| | - Jiangjiang Zhang
- CAS Center for Excellence in Nanoscience, Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology, No. 11, BeiYiTiao, ZhongGuanCun, Beijing, 100190, China
| | - Xiyong Yu
- Guangdong Key Laboratory of Molecular Target &, Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third & Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China
| | - Wenfu Zheng
- CAS Center for Excellence in Nanoscience, Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology, No. 11, BeiYiTiao, ZhongGuanCun, Beijing, 100190, China
| | - Xingyu Jiang
- Department of Biomedical Engineering, Southern University of Science and Technology, No. 1088 Xueyuan Rd, Nanshan District, Shenzhen, Guangdong, 518055, China.,CAS Center for Excellence in Nanoscience, Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology, No. 11, BeiYiTiao, ZhongGuanCun, Beijing, 100190, China.,Guangdong Key Laboratory of Molecular Target &, Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, The Third & Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China.,University of Chinese Academy of Sciences, Beijing, 100049, China
| |
Collapse
|
12
|
Zhang L, Wang L, Xie Y, Wang P, Deng S, Qin A, Zhang J, Yu X, Zheng W, Jiang X. Triple‐Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases. Angew Chem Int Ed Engl 2019. [DOI: 10.1002/ange.201903618] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Lingmin Zhang
- CAS Center for Excellence in NanoscienceBeijing Engineering Research Center for BioNanotechnologyCAS Key Lab for Biological Effects of Nanomaterials and NanosafetyNational Center for NanoScience and Technology No. 11, BeiYiTiao, ZhongGuanCun Beijing 100190 China
- Guangdong Key Laboratory of Molecular Target &, Clinical PharmacologyState Key Laboratory of Respiratory DiseaseSchool of Pharmaceutical SciencesThe Third & Fifth Affiliated HospitalGuangzhou Medical University Guangzhou Guangdong 511436 China
| | - Le Wang
- CAS Center for Excellence in NanoscienceBeijing Engineering Research Center for BioNanotechnologyCAS Key Lab for Biological Effects of Nanomaterials and NanosafetyNational Center for NanoScience and Technology No. 11, BeiYiTiao, ZhongGuanCun Beijing 100190 China
| | - Yangzhouyun Xie
- CAS Center for Excellence in NanoscienceBeijing Engineering Research Center for BioNanotechnologyCAS Key Lab for Biological Effects of Nanomaterials and NanosafetyNational Center for NanoScience and Technology No. 11, BeiYiTiao, ZhongGuanCun Beijing 100190 China
| | - Peng Wang
- CAS Center for Excellence in NanoscienceBeijing Engineering Research Center for BioNanotechnologyCAS Key Lab for Biological Effects of Nanomaterials and NanosafetyNational Center for NanoScience and Technology No. 11, BeiYiTiao, ZhongGuanCun Beijing 100190 China
| | - Sai Deng
- Guangdong Key Laboratory of Molecular Target &, Clinical PharmacologyState Key Laboratory of Respiratory DiseaseSchool of Pharmaceutical SciencesThe Third & Fifth Affiliated HospitalGuangzhou Medical University Guangzhou Guangdong 511436 China
| | - Aiping Qin
- Guangdong Key Laboratory of Molecular Target &, Clinical PharmacologyState Key Laboratory of Respiratory DiseaseSchool of Pharmaceutical SciencesThe Third & Fifth Affiliated HospitalGuangzhou Medical University Guangzhou Guangdong 511436 China
| | - Jiangjiang Zhang
- CAS Center for Excellence in NanoscienceBeijing Engineering Research Center for BioNanotechnologyCAS Key Lab for Biological Effects of Nanomaterials and NanosafetyNational Center for NanoScience and Technology No. 11, BeiYiTiao, ZhongGuanCun Beijing 100190 China
| | - Xiyong Yu
- Guangdong Key Laboratory of Molecular Target &, Clinical PharmacologyState Key Laboratory of Respiratory DiseaseSchool of Pharmaceutical SciencesThe Third & Fifth Affiliated HospitalGuangzhou Medical University Guangzhou Guangdong 511436 China
| | - Wenfu Zheng
- CAS Center for Excellence in NanoscienceBeijing Engineering Research Center for BioNanotechnologyCAS Key Lab for Biological Effects of Nanomaterials and NanosafetyNational Center for NanoScience and Technology No. 11, BeiYiTiao, ZhongGuanCun Beijing 100190 China
| | - Xingyu Jiang
- Department of Biomedical EngineeringSouthern University of Science and Technology No. 1088 Xueyuan Rd, Nanshan District Shenzhen Guangdong 518055 China
- CAS Center for Excellence in NanoscienceBeijing Engineering Research Center for BioNanotechnologyCAS Key Lab for Biological Effects of Nanomaterials and NanosafetyNational Center for NanoScience and Technology No. 11, BeiYiTiao, ZhongGuanCun Beijing 100190 China
- Guangdong Key Laboratory of Molecular Target &, Clinical PharmacologyState Key Laboratory of Respiratory DiseaseSchool of Pharmaceutical SciencesThe Third & Fifth Affiliated HospitalGuangzhou Medical University Guangzhou Guangdong 511436 China
- University of Chinese Academy of Sciences Beijing 100049 China
| |
Collapse
|
13
|
|
14
|
Wang L, Zheng W, Liu S, Li B, Jiang X. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy. Chembiochem 2018; 20:634-643. [PMID: 30393919 DOI: 10.1002/cbic.201800629] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2018] [Indexed: 01/03/2023]
Abstract
Precise editing of the genome of a living body is a goal pursued by scientists in many fields. In recent years, CRISPR (clustered regularly interspaced short palindromic repeat)/Cas (CRISPR-associated) genome-editing systems have become a revolutionary toolbox for gene editing across various species. However, the low transfection efficiency of the CRISPR/Cas9 system to mammalian cells in vitro and in vivo is a big obstacle hindering wide and deep application. In this review, recently developed delivery strategies for various CRISPR/Cas9 formulations and their applications in treating gene-related diseases are briefly summarized. This review should inspire others to explore more efficient strategies for CRISPR system delivery and gene therapy.
Collapse
Affiliation(s)
- Le Wang
- School of Life Science and Technology, Harbin Institute of Technology, 2 Yikuang Road, Nangang District, Harbin, 150001, China.,Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, CAS Center of Excellence for Nanoscience, National Center for NanoScience and Technology, Beijing, 100190, China
| | - Wenfu Zheng
- Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, CAS Center of Excellence for Nanoscience, National Center for NanoScience and Technology, Beijing, 100190, China
| | - Shaoqin Liu
- School of Life Science and Technology, Harbin Institute of Technology, 2 Yikuang Road, Nangang District, Harbin, 150001, China
| | - Bing Li
- Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, CAS Center of Excellence for Nanoscience, National Center for NanoScience and Technology, Beijing, 100190, China.,Biomedical Engineering Institute, Jinan University, No.601, West Huangpu Avenue, TianHe District, Guangzhou, 510632, China
| | - Xingyu Jiang
- School of Life Science and Technology, Harbin Institute of Technology, 2 Yikuang Road, Nangang District, Harbin, 150001, China.,Beijing Engineering Research Center for BioNanotechnology, CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety, CAS Center of Excellence for Nanoscience, National Center for NanoScience and Technology, Beijing, 100190, China.,Department of Biomedical Engineering, Southern University of Science and Technology, No. 1088 Xueyuan Road, Nanshan District, Shenzhen, Guangdong, 518055, China
| |
Collapse
|
15
|
Zhou W, Cui H, Ying L, Yu XF. Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing. Angew Chem Int Ed Engl 2018; 57:10268-10272. [DOI: 10.1002/anie.201806941] [Citation(s) in RCA: 121] [Impact Index Per Article: 20.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2018] [Indexed: 12/23/2022]
Affiliation(s)
- Wenhua Zhou
- Center for Biomedical Materials and Interfaces; Shenzhen Institutes of Advanced Technology; Chinese Academy of Sciences; Shenzhen 518055 P. R. China
| | - Haodong Cui
- Center for Biomedical Materials and Interfaces; Shenzhen Institutes of Advanced Technology; Chinese Academy of Sciences; Shenzhen 518055 P. R. China
| | - Liming Ying
- Molecular Medicine, National Heart and Lung Institute; Imperial College London; London SW7 2AZ UK
| | - Xue-Feng Yu
- Center for Biomedical Materials and Interfaces; Shenzhen Institutes of Advanced Technology; Chinese Academy of Sciences; Shenzhen 518055 P. R. China
| |
Collapse
|
16
|
Zhou W, Cui H, Ying L, Yu XF. Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing. Angew Chem Int Ed Engl 2018. [DOI: 10.1002/ange.201806941] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Wenhua Zhou
- Center for Biomedical Materials and Interfaces; Shenzhen Institutes of Advanced Technology; Chinese Academy of Sciences; Shenzhen 518055 P. R. China
| | - Haodong Cui
- Center for Biomedical Materials and Interfaces; Shenzhen Institutes of Advanced Technology; Chinese Academy of Sciences; Shenzhen 518055 P. R. China
| | - Liming Ying
- Molecular Medicine, National Heart and Lung Institute; Imperial College London; London SW7 2AZ UK
| | - Xue-Feng Yu
- Center for Biomedical Materials and Interfaces; Shenzhen Institutes of Advanced Technology; Chinese Academy of Sciences; Shenzhen 518055 P. R. China
| |
Collapse
|